• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在同基因 SW480/SW620 结直肠癌细胞模型中敲低后的 -聚糖和蛋白质标志物的高通量质谱分析。

High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers after Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model.

机构信息

Doctoral Program in Methods and Applications in Life Sciences, Faculty of Biology, Universidade de Vigo, Campus Lagoas-Marcosende, 36310 Vigo, Pontevedra (Galicia), Spain.

Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), CIBERONC, Travesía da Choupana, 15706 Santiago de Compostela, A Coruña (Galicia), Spain.

出版信息

J Proteome Res. 2024 Apr 5;23(4):1379-1398. doi: 10.1021/acs.jproteome.3c00833. Epub 2024 Mar 20.

DOI:10.1021/acs.jproteome.3c00833
PMID:38507902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11002942/
Abstract

Disruption of the glycosylation machinery is a common feature in many types of cancer, and colorectal cancer (CRC) is no exception. Core fucosylation is mediated by the enzyme fucosyltransferase 8 (FucT-8), which catalyzes the addition of α1,6-l-fucose to the innermost GlcNAc residue of -glycans. We and others have documented the involvement of FucT-8 and core-fucosylated proteins in CRC progression, in which we addressed core fucosylation in the syngeneic CRC model formed by SW480 and SW620 tumor cell lines from the perspective of alterations in their -glycosylation profile and protein expression as an effect of the knockdown of the gene that encodes FucT-8. Using label-free, semiquantitative mass spectrometry (MS) analysis, we found noticeable differences in -glycosylation patterns in -knockdown cells, affecting core fucosylation and sialylation, the Hex/HexNAc , and antennarity. Furthermore, stable isotopic labeling of amino acids in cell culture (SILAC)-based proteomic screening detected the alteration of species involved in protein folding, endoplasmic reticulum (ER) and Golgi post-translational stabilization, epithelial polarity, and cellular response to damage and therapy. This data is available via ProteomeXchange with identifier PXD050012. Overall, the results obtained merit further investigation to validate their feasibility as biomarkers of progression and malignization in CRC, as well as their potential usefulness in clinical practice.

摘要

糖基化机制的破坏是许多类型癌症的共同特征,结直肠癌(CRC)也不例外。核心岩藻糖基化是由岩藻糖基转移酶 8(FucT-8)介导的,它催化α1,6-l-岩藻糖添加到 -糖链的最内 GlcNAc 残基上。我们和其他人已经记录了 FucT-8 和核心岩藻糖基化蛋白在 CRC 进展中的参与,在这项研究中,我们从 SW480 和 SW620 肿瘤细胞系形成的同源 CRC 模型的角度研究了核心岩藻糖基化,该模型涉及到 -糖基化谱和蛋白质表达的改变,这是由于 FucT-8 编码基因的敲低所致。使用无标记、半定量质谱(MS)分析,我们发现 -敲低细胞中的 -糖基化模式发生了明显的变化,影响了核心岩藻糖基化和唾液酸化、Hex/HexNAc 、和天线分支。此外,基于稳定同位素标记的氨基酸细胞培养(SILAC)的蛋白质组筛选检测到涉及蛋白质折叠、内质网(ER)和高尔基体翻译后稳定、上皮极性和细胞对损伤和治疗反应的物种的改变。这些数据可通过 ProteomeXchange 获得,标识符为 PXD050012。总的来说,这些结果值得进一步研究,以验证它们作为 CRC 进展和恶性转化的生物标志物的可行性,以及它们在临床实践中的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/b57f19077a3b/pr3c00833_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/07602deccc0d/pr3c00833_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/212c8f3d0176/pr3c00833_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/881ff23a29a3/pr3c00833_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/f854ee3f01de/pr3c00833_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/b57f19077a3b/pr3c00833_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/07602deccc0d/pr3c00833_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/212c8f3d0176/pr3c00833_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/881ff23a29a3/pr3c00833_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/f854ee3f01de/pr3c00833_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2145/11002942/b57f19077a3b/pr3c00833_0005.jpg

相似文献

1
High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers after Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model.在同基因 SW480/SW620 结直肠癌细胞模型中敲低后的 -聚糖和蛋白质标志物的高通量质谱分析。
J Proteome Res. 2024 Apr 5;23(4):1379-1398. doi: 10.1021/acs.jproteome.3c00833. Epub 2024 Mar 20.
2
Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells.核心岩藻糖基化由 FucT-8 酶介导影响 TRAIL 诱导的凋亡和对人 SW480 和 SW620 结肠癌细胞化疗的敏感性。
Int J Mol Sci. 2023 Jul 25;24(15):11879. doi: 10.3390/ijms241511879.
3
Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans.哺乳动物α-1,6-岩藻糖基转移酶(FUT8)是负责高甘露糖型N-聚糖的不依赖于N-乙酰葡糖胺基转移酶I的核心岩藻糖基化的唯一酶。
J Biol Chem. 2016 May 20;291(21):11064-71. doi: 10.1074/jbc.M116.720789. Epub 2016 Mar 23.
4
Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model.抑制α(1,6)岩藻糖基转移酶:对 SW480/SW620 同源结直肠癌模型中细胞增殖、迁移和黏附的影响。
Int J Mol Sci. 2022 Jul 30;23(15):8463. doi: 10.3390/ijms23158463.
5
Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of -glycans lacking α1,3-arm GlcNAc.重新审视哺乳动物α1,6-岩藻糖基转移酶的底物特异性发现,它催化缺乏α1,3-臂GlcNAc的聚糖的核心岩藻糖基化。
J Biol Chem. 2017 Sep 8;292(36):14796-14803. doi: 10.1074/jbc.M117.804070. Epub 2017 Jul 20.
6
Appropriate aglycone modification significantly expands the glycan substrate acceptability of α1,6-fucosyltransferase (FUT8).适当的糖苷配基修饰显著扩大了α1,6-岩藻糖基转移酶(FUT8)的糖基供体接受性。
Biochem J. 2021 Apr 30;478(8):1571-1583. doi: 10.1042/BCJ20210138.
7
FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.癌症中的 FUT8 Alpha-(1,6)-Fucosyltransferase。
Int J Mol Sci. 2021 Jan 5;22(1):455. doi: 10.3390/ijms22010455.
8
Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.肝细胞癌的综合N-聚糖谱揭示了岩藻糖基化与肿瘤进展的关联以及微小RNA对FUT8的调控。
Oncotarget. 2016 Sep 20;7(38):61199-61214. doi: 10.18632/oncotarget.11284.
9
FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.FUT8 通过重塑 TGF-β 受体核心岩藻糖基化促进乳腺癌细胞侵袭。
Breast Cancer Res. 2017 Oct 5;19(1):111. doi: 10.1186/s13058-017-0904-8.
10
Core fucosylation within the Fc-FcγR degradation pathway promotes enhanced IgG levels via exogenous L-fucose.Fc-FcγR 降解途径中的核心岩藻糖基化通过外源性 L-岩藻糖促进 IgG 水平的提高。
J Biol Chem. 2024 Aug;300(8):107558. doi: 10.1016/j.jbc.2024.107558. Epub 2024 Jul 11.

引用本文的文献

1
The Role of Proteomics and Genomics in the Development of Colorectal Cancer Diagnostic Tools and Potential New Treatments.蛋白质组学和基因组学在结直肠癌诊断工具开发及潜在新疗法中的作用
ACS Pharmacol Transl Sci. 2025 Apr 10;8(5):1227-1250. doi: 10.1021/acsptsci.4c00686. eCollection 2025 May 9.
2
Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.将岩藻糖基转移酶FUT8作为弥漫性大B细胞淋巴瘤(DLBCL)的一种潜在治疗方法。
Oncogenesis. 2025 Jan 29;14(1):1. doi: 10.1038/s41389-025-00544-7.

本文引用的文献

1
Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells.核心岩藻糖基化由 FucT-8 酶介导影响 TRAIL 诱导的凋亡和对人 SW480 和 SW620 结肠癌细胞化疗的敏感性。
Int J Mol Sci. 2023 Jul 25;24(15):11879. doi: 10.3390/ijms241511879.
2
Mathematical modeling the order of driver gene mutations in colorectal cancer.数学建模结直肠癌中驱动基因突变的顺序。
PLoS Comput Biol. 2023 Jun 27;19(6):e1011225. doi: 10.1371/journal.pcbi.1011225. eCollection 2023 Jun.
3
FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response.
HYOU1 的 FUT2 依赖性岩藻糖基化通过调节未折叠蛋白反应保护肠道干细胞免受炎症损伤。
Redox Biol. 2023 Apr;60:102618. doi: 10.1016/j.redox.2023.102618. Epub 2023 Jan 28.
4
Targeting ARF1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance.靶向 ARF1-IQGAP1 相互作用抑制结直肠癌转移和vemurafenib 耐药性。
J Adv Res. 2023 Sep;51:135-147. doi: 10.1016/j.jare.2022.11.006. Epub 2022 Nov 14.
5
Proteome and Glycoproteome Analyses Reveal the Protein N-Linked Glycosylation Specificity of STT3A and STT3B.蛋白质组和糖蛋白质组分析揭示 STT3A 和 STT3B 的蛋白 N-连接糖基化特异性。
Cells. 2022 Sep 6;11(18):2775. doi: 10.3390/cells11182775.
6
Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model.抑制α(1,6)岩藻糖基转移酶:对 SW480/SW620 同源结直肠癌模型中细胞增殖、迁移和黏附的影响。
Int J Mol Sci. 2022 Jul 30;23(15):8463. doi: 10.3390/ijms23158463.
7
An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.基于质谱的糖组学驱动糖蛋白质组学分析平台,用于功能表征糖基化抑制剂。
Molecules. 2022 Jun 14;27(12):3834. doi: 10.3390/molecules27123834.
8
Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases.结直肠癌肝转移的蛋白质组学分析和生物标志物发现
Int J Mol Sci. 2022 May 29;23(11):6091. doi: 10.3390/ijms23116091.
9
FUT8-Directed Core Fucosylation of N-glycans Is Regulated by the Glycan Structure and Protein Environment.N-聚糖的岩藻糖基转移酶8介导的核心岩藻糖基化受聚糖结构和蛋白质环境的调控。
ACS Catal. 2021 Aug 6;11(15):9052-9065. doi: 10.1021/acscatal.1c01698. Epub 2021 Jul 8.
10
High-Mannose -Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer.高甘露糖聚糖作为早期结直肠癌恶性进展的标志物
Cancers (Basel). 2022 Mar 18;14(6):1552. doi: 10.3390/cancers14061552.